Biotech short seller lands on feds' watch list amid sweeping probe — report
In the face of short attacks, it is not uncommon these days for companies to cry foul and defend themselves against what they call false …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
